US Patent Issued to Boehringer Ingelheim International on Oct. 27 for "Recombinant rhabdovirus encoding for a CD80 extracellular domain Fc-fusion protein" (Austrian, German Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,436, issued on Oct. 27, was assigned to Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany).

"Recombinant rhabdovirus encoding for a CD80 extracellular domain Fc-fusion protein" was invented by Philipp Mueller (Mittelbiberach, Germany), Klaus Erb (Mittelbiberach, Germany), Patrik Erlmann (Goetzens, Austria) and Guido Wollmann (Innsbruck, Austria).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the field of oncolytic viruses and in particular to a recombinant rhabdovirus, such as vesicular stomatitis virus encoding in its genome for a CD80 extracellular domain Fc-fusion protein. The invention is furthe...